Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Roger's 1998 Short Picks -- Ignore unavailable to you. Want to Upgrade?

To: Dauntless who wrote (5558)	3/26/1998 8:56:00 AM
From: clochard	Read Replies (1) \| Respond to of 18691

What Zonagen is trying to do to the investment public can also be described as vulgar. All the available information about Zonagen would leave an experienced investor very sceptical, and having you as their spokesperson makes it worse because you don't seem to have a lot of evidence to help them. Having a patent on a drug is little. Having a patent on a drug that doesn't seem to work is even less. All your ranting can't change that fact, and citing anecdotal facts and opinions won't convince anyone.

To: Dauntless who wrote (5558)	3/26/1998 12:08:00 PM
From: Joey Two-Cents	Respond to of 18691

Is this the 6th or 7th filing against ZONA? Losing count. biz.yahoo.com

To: Dauntless who wrote (5558)	3/27/1998 4:53:00 PM
From: Bill Wexler	Read Replies (2) \| Respond to of 18691

The Zonagen fraud will soon come to an end. Today Pfizer's Viagra was approved. Viagra is a legitimate treatment for MED. Zonagen went down significantly today on news of additional shareholder lawsuits and the realization that Pfizer will own the market. Of course, this was never in doubt. Vasomax's only active ingredient is Phentolamine. Phentolamine is absolutely worthless for the treatment of ED. Zonagen has repeatedly lied to investors and has committed patent fraud in the past with Immumax. Zonagen will soon...and inevitably....trade in the low single digits.